14.00
price down icon1.41%   -0.20
after-market Handel nachbörslich: 13.80 -0.20 -1.43%
loading
Schlusskurs vom Vortag:
$14.20
Offen:
$14.25
24-Stunden-Volumen:
875.37K
Relative Volume:
0.68
Marktkapitalisierung:
$1.36B
Einnahmen:
$221.08M
Nettoeinkommen (Verlust:
$-2.92M
KGV:
280.00
EPS:
0.05
Netto-Cashflow:
$5.89M
1W Leistung:
-6.73%
1M Leistung:
-11.45%
6M Leistung:
+96.35%
1J Leistung:
+8.02%
1-Tages-Spanne:
Value
$13.83
$14.27
1-Wochen-Bereich:
Value
$13.83
$15.20
52-Wochen-Spanne:
Value
$6.38
$16.66

Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile

Name
Firmenname
Avadel Pharmaceuticals Plc
Name
Telefon
636-449-1830
Name
Adresse
BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN
Name
Mitarbeiter
188
Name
Twitter
@AvadelPharma
Name
Nächster Verdiensttermin
2025-03-03
Name
Neueste SEC-Einreichungen
Name
AVDL's Discussions on Twitter

Vergleichen Sie AVDL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
AVDL
Avadel Pharmaceuticals Plc
14.00 1.38B 221.08M -2.92M 5.89M 0.05
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
141.11 63.55B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.71 44.47B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.00 40.17B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.03 22.99B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
440.00 20.14B 3.08B 1.24B 1.07B 25.61

Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-03 Eingeleitet Wells Fargo Equal Weight
2025-07-18 Fortgesetzt H.C. Wainwright Buy
2025-02-11 Eingeleitet Deutsche Bank Buy
2024-06-12 Eingeleitet Rodman & Renshaw Buy
2024-03-05 Bestätigt H.C. Wainwright Buy
2024-03-05 Bestätigt Needham Buy
2024-03-05 Bestätigt Oppenheimer Outperform
2024-02-06 Eingeleitet UBS Buy
2022-11-30 Hochstufung Jefferies Hold → Buy
2022-08-10 Herabstufung Jefferies Buy → Hold
2022-07-28 Fortgesetzt Craig Hallum Buy
2022-05-26 Herabstufung Stifel Buy → Hold
2021-09-23 Eingeleitet Needham Buy
2020-07-31 Eingeleitet Oppenheimer Outperform
2020-07-21 Eingeleitet SVB Leerink Outperform
2020-06-30 Eingeleitet H.C. Wainwright Buy
2020-04-03 Eingeleitet Jefferies Buy
2020-03-12 Eingeleitet Stifel Buy
2020-02-26 Eingeleitet Piper Sandler Overweight
2020-01-30 Eingeleitet Craig Hallum Buy
2019-06-14 Hochstufung Ladenburg Thalmann Neutral → Buy
2019-02-08 Herabstufung Ladenburg Thalmann Buy → Neutral
Alle ansehen

Avadel Pharmaceuticals Plc Aktie (AVDL) Neueste Nachrichten

pulisher
07:59 AM

Q3 Earnings Forecast for AVDL Issued By Leerink Partnrs - MarketBeat

07:59 AM
pulisher
06:35 AM

Should you hold or exit Avadel Pharmaceuticals plc nowTrade Analysis Report & Low Drawdown Investment Strategies - newser.com

06:35 AM
pulisher
05:07 AM

Using economic indicators to assess Avadel Pharmaceuticals plc potentialEarnings Miss & Low Risk High Reward Ideas - newser.com

05:07 AM
pulisher
Oct 09, 2025

Avadel Pharmaceuticals (NASDAQ:AVDL) Given Sell (E+) Rating at Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

What drives Avadel Pharmaceuticals plc stock priceTrading Psychology Tips & Exceptional Profit Ideas - earlytimes.in

Oct 09, 2025
pulisher
Oct 09, 2025

Avadel Pharmaceuticals plc stock trend forecastJuly 2025 Highlights & Weekly Breakout Opportunity Watchlist - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Using portfolio simulators with Avadel Pharmaceuticals plc includedPortfolio Update Summary & Real-Time Chart Pattern Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is Avadel Pharmaceuticals plc (AWK) stock a contrarian opportunityJuly 2025 Price Swings & High Conviction Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Volatility clustering patterns for Avadel Pharmaceuticals plc2025 Major Catalysts & Capital Protection Trading Alerts - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

Can Avadel Pharmaceuticals plc (AWK) stock hold up in economic slowdownMarket Risk Analysis & Real-Time Volume Trigger Notifications - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Is Avadel Pharmaceuticals plc stock a defensive play in 2025July 2025 Sector Moves & Safe Entry Point Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Analysts Expect Avadel Pharmaceuticals plc (NASDAQ:AVDL) To Breakeven Soon - Yahoo Finance

Oct 05, 2025
pulisher
Oct 05, 2025

Custom strategy builders for tracking Avadel Pharmaceuticals plcDollar Strength & Safe Capital Growth Trade Ideas - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

How strong is Avadel Pharmaceuticals plc (AWK) stock earnings growthMarket Performance Report & Community Shared Stock Ideas - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Can Avadel Pharmaceuticals plc stock withstand economic slowdownMarket Movement Recap & Step-by-Step Trade Execution Guides - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Why Avadel Pharmaceuticals plc (AWK) stock trades below fair valueJuly 2025 Selloffs & Trade Opportunity Analysis Reports - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Is Avadel Pharmaceuticals plc stock attractive after correctionRisk Management & Daily Entry Point Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is Avadel Pharmaceuticals plc (AWK) stock good for long term investingWeekly Trade Recap & Precise Buy Zone Identification - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

How to build a custom watchlist for Avadel Pharmaceuticals plcWeekly Market Outlook & Momentum Based Trading Ideas - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Is Avadel Pharmaceuticals plc a good long term investmentCovered Call Writing & Make Confident Moves With Forecasting Models - earlytimes.in

Oct 02, 2025
pulisher
Oct 01, 2025

Will Avadel Pharmaceuticals plc stock maintain dividend yieldQuarterly Growth Report & AI Driven Stock Reports - newser.com

Oct 01, 2025
pulisher
Sep 30, 2025

Avadel: Mispriced Leader In Once-Nightly Sleep Therapies - Seeking Alpha

Sep 30, 2025
pulisher
Sep 30, 2025

What analysts say about Avadel Pharmaceuticals plc stockBollinger Bands Signals & Free Stock Trading Signal Access - earlytimes.in

Sep 30, 2025
pulisher
Sep 29, 2025

Avadel Pharmaceuticals gains as holder pushes for sale process - MSN

Sep 29, 2025
pulisher
Sep 29, 2025

Does Avadel Pharmaceuticals plc fit your quant trading modelMarket Weekly Review & Verified Chart Pattern Trade Signals - newser.com

Sep 29, 2025
pulisher
Sep 28, 2025

Avadel Pharmaceuticals plc AWK Stock Analysis and ForecastMarket Sentiment Extremes & Small Investment Capital Tips - earlytimes.in

Sep 28, 2025
pulisher
Sep 28, 2025

Avadel Pharmaceuticals (NASDAQ:AVDL) Stock Rating Upgraded by Wall Street Zen - MarketBeat

Sep 28, 2025
pulisher
Sep 28, 2025

Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Given Consensus Rating of "Buy" by Analysts - MarketBeat

Sep 28, 2025
pulisher
Sep 27, 2025

Avadel Pharmaceuticals Plc's (NASDAQ:AVDL) Institutional Investors Lost 5.3% Last Week but Have Benefitted From Longer-term Gains - 富途牛牛

Sep 27, 2025
pulisher
Sep 26, 2025

Avadel Obtains FDA Nod for Label Expansion of Narcolepsy Drug Lumryz - MSN

Sep 26, 2025
pulisher
Sep 24, 2025

Why The Story Around Avadel Pharmaceuticals Is Evolving After Recent Analyst and Market Updates - Sahm

Sep 24, 2025
pulisher
Sep 23, 2025

Avadel Pharmaceuticals (NASDAQ:AVDL) Rating Lowered to "Buy" at Wall Street Zen - MarketBeat

Sep 23, 2025

Finanzdaten der Avadel Pharmaceuticals Plc-Aktie (AVDL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Avadel Pharmaceuticals Plc-Aktie (AVDL) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Thornton Peter J.
Director
Jan 13 '25
Buy
8.04
10,000
80,450
104,055
Ende Eric J
Director
Jan 13 '25
Buy
7.84
30,000
235,218
208,900
MCHUGH THOMAS S
Chief Financial Officer
Dec 13 '24
Buy
10.44
2,300
24,019
87,800
MCHUGH THOMAS S
Chief Financial Officer
Dec 11 '24
Buy
10.49
5,000
52,432
85,500
Divis Gregory J
Chief Executive Officer
Dec 06 '24
Buy
9.98
9,598
95,759
9,598
Divis Gregory J
Chief Executive Officer
Dec 09 '24
Buy
9.82
402
3,948
10,000
Glass Geoffrey Michael
Director
Dec 10 '24
Buy
9.84
20,279
199,641
75,904
Palczuk Linda
Director
Dec 06 '24
Buy
10.19
3,000
30,568
66,400
$19.76
price down icon 1.54%
$9.74
price down icon 2.50%
$53.95
price down icon 7.38%
drug_manufacturers_specialty_generic RDY
$14.34
price up icon 1.20%
$136.63
price down icon 1.33%
$440.00
price down icon 1.21%
Kapitalisierung:     |  Volumen (24h):